Incannex Healthcare Limited (IXHL) Income Statement

NASDAQ: IXHLRevenue, profits, margins and EPS over 2 years.

IXHL FY2026 at a glance

Fiscal year ended June 30, 2026 · U.S. dollars
Revenue−100.0%
$0
FY2026 · hover or tap a bar for each year
FY2025: $86,000FY2026: $0 (−100.0%)
FY2025FY2026
Gross profit
−$240,000
FY2026 · hover or tap a bar for each year
FY2025: −$160,000FY2026: −$240,000
FY2025FY2026
Operating income
−$23.0M
FY2026 · hover or tap a bar for each year
FY2025: −$23.8MFY2026: −$23.0M
FY2025FY2026
Net income
−$19.3M
FY2026 · hover or tap a bar for each year
FY2025: −$46.9MFY2026: −$19.3M
FY2025FY2026
EPS (diluted)
−$2.40
FY2026 · hover or tap a bar for each year
FY2025: −$29.99FY2026: −$2.40
FY2025FY2026

IXHL revenue and net income

RevenueNet incomeNet margin (right axis)

IXHL profit margins

GrossOperatingNet

IXHL growth rates

to FY2026
1 year3 years5 years10 years
Revenue−100.0%———
Gross profit————
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

IXHL quarterly EPS vs estimates

Reported EPSAnalyst estimate

Incannex Healthcare beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: November 13, 2026 (estimate $-0.66).

IXHL income statement

Incannex Healthcare Limited annual income statement
FY2026FY2025
Revenue$0$86,000
Cost of revenue$240,000$246,000
Gross profit−$240,000−$160,000
Research & development$5.2M$10.7M
Sales, general & admin$17.8M$13.1M
Total operating expenses$22.8M$23.6M
Operating income−$23.0M−$23.8M
Interest expense—$303,000
Income before taxes−$24.0M−$48.6M
Income taxes−$4.7M−$1.8M
Net income−$19.3M−$46.9M
EBITDA−$22.8M−$23.5M
EPS (diluted)−$2.40−$29.99
Gross margin—−186.0%
Operating margin—−27,661.6%
Net margin—−54,517.4%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in IXHL's financial statements (latest annual report filed September 25, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

IXHL financial results

Incannex Healthcare reported no revenue in fiscal year 2026 (ended June 30, 2026). It had a net loss of $19.3 million. Diluted earnings per share came to −$2.40.

See the IXHL stock overview for the latest quote and news, or the IXHL chart for price history and technical indicators.

IXHL income statement FAQ

Does Incannex Healthcare have revenue?

Incannex Healthcare reported no revenue for fiscal year 2026, which ended on June 30, 2026.

Is Incannex Healthcare profitable?

No. Incannex Healthcare reported a net loss of $19.3 million in fiscal 2026.

How much does Incannex Healthcare spend on research and development?

Incannex Healthcare spent $5.2 million on research and development in fiscal 2026.

What are Incannex Healthcare's earnings per share?

Incannex Healthcare earned $-2.40 per diluted share in fiscal 2026, compared with $-29.99 a year earlier.

When will Incannex Healthcare report its next earnings?

Incannex Healthcare is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.

When does Incannex Healthcare's fiscal year end?

Incannex Healthcare's fiscal year ends in June. The latest annual report covers the year ended June 30, 2026 and was filed on September 25, 2026.

Drug Manufacturers - Specialty & Generic income statements